Follow the 제이시스메디칼 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 제이시스메디칼 has recorded 109 public disclosures. The latest transaction was disclosed on 25 October 2024 (Purchase). Among the most active insiders: 선혜진. All data is accessible without an account.
109
Insider Decl.
0
Thresholds
·
32 ops.
Buy Volume
·
19 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.